Wedge Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $246K | Sell |
3,143
-480
| -13% | -$38.7K | ﹤0.01% | 465 |
|
|
2026
Q1 | $314K | Buy |
3,623
+704
| +24% | +$67.4K | 0.01% | 495 |
|
|
2025
Q4 | $280K | Buy |
2,919
+202
| +7% | +$19.6K | 0.01% | 497 |
|
|
2025
Q3 | $259K | Buy |
2,717
+20
| +0.7% | +$1.84K | ﹤0.01% | 514 |
|
|
2025
Q2 | $235K | Buy |
2,697
+164
| +6% | +$13.9K | ﹤0.01% | 499 |
|
|
2025
Q1 | $228K | Sell |
2,533
-118
| -4% | -$10.6K | ﹤0.01% | 506 |
|
|
2024
Q4 | $212K | Hold |
2,651
| – | – | ﹤0.01% | 504 |
|
|
2024
Q3 | $239K | Buy |
2,651
+98
| +4% | +$8.24K | ﹤0.01% | 491 |
|
|
2024
Q2 | $201K | Sell |
2,553
-367
| -13% | -$30.1K | ﹤0.01% | 481 |
|
|
2024
Q1 | $254K | Buy |
2,920
+139
| +5% | +$11.9K | ﹤0.01% | 479 |
|
|
2023
Q4 | $229K | Sell |
2,781
-119
| -4% | -$9.07K | ﹤0.01% | 476 |
|
|
2023
Q3 | $227K | Buy |
2,900
+333
| +13% | +$27.9K | ﹤0.01% | 480 |
|
|
2023
Q2 | $226K | Sell |
2,567
-43
| -2% | -$3.7K | ﹤0.01% | 499 |
|
|
2023
Q1 | $210K | Hold |
2,610
| – | – | ﹤0.01% | 403 |
|
|
2022
Q4 | $203K | Buy |
2,610
+107
| +4% | +$8.67K | ﹤0.01% | 401 |
|
|
2022
Q3 | $202K | Sell |
2,503
-94
| -4% | -$8.45K | ﹤0.01% | 384 |
|
|
2022
Q2 | $233K | Sell |
2,597
-36
| -1% | -$3.65K | ﹤0.01% | 376 |
|
|
2022
Q1 | $292K | Buy |
2,633
+92
| +4% | +$9.72K | ﹤0.01% | 361 |
|
|
2021
Q4 | $263K | Hold |
2,541
| – | – | ﹤0.01% | 363 |
|
|
2021
Q3 | $319K | Buy |
+2,541
| New | +$329K | ﹤0.01% | 343 |
|
|
2021
Q2 | – | Sell |
-3,115
| Closed | -$368K | – | 473 |
|
|
2021
Q1 | $368K | Sell |
3,115
-291
| -9% | -$34.1K | ﹤0.01% | 410 |
|
|
2020
Q4 | $399K | Buy |
3,406
+69
| +2% | +$7.6K | ﹤0.01% | 429 |
|
|
2020
Q3 | $347K | Buy |
3,337
+185
| +6% | +$18.6K | ﹤0.01% | 423 |
|
|
2020
Q2 | $289K | Sell |
3,152
-43
| -1% | -$4.12K | ﹤0.01% | 425 |
|
|
2020
Q1 | $288K | Buy |
3,195
+131
| +4% | +$13.9K | 0.01% | 405 |
|
|
2019
Q4 | $348K | Buy |
3,064
+53
| +2% | +$5.82K | ﹤0.01% | 444 |
|
|
2019
Q3 | $327K | Sell |
3,011
-28
| -0.9% | -$2.92K | ﹤0.01% | 468 |
|
|
2019
Q2 | $296K | Buy |
+3,039
| New | +$277K | ﹤0.01% | 531 |
|
|
2018
Q4 | – | Sell |
-2,199
| Closed | -$216K | – | 579 |
|
|
2018
Q3 | $216K | Sell |
2,199
-333,140
| -99% | -$30.8M | ﹤0.01% | 561 |
|
|
2018
Q2 | $28.7M | Sell |
335,339
-97,708
| -23% | -$8.16M | 0.28% | 118 |
|
|
2018
Q1 | $34.7M | Sell |
433,047
-136,342
| -24% | -$11.2M | 0.33% | 85 |
|
|
2017
Q4 | $46M | Buy |
+569,389
| New | +$45.6M | 0.41% | 64 |
|
Other funds holding MDT
LMFP
FWIA
SRIM
DC
CAI
VF
Wedge Capital Management's MDT Position: Q2 2026 in Review
Wedge Capital Management reduced its Medtronic (MDT) stake by 13% in Q2 2026, selling an estimated $38.7K and leaving 3,143 shares worth $246K. The position accounts for ﹤0.01% of the portfolio, ranked #465.
Wedge Capital Management first reported a position in MDT in Q4 2017 and has held it in 32 quarters since. The position peaked at $46M in Q4 2017. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Wedge Capital Management held 3,143 shares of Medtronic worth $246K as of Q2 2026.
- Wedge Capital Management sold 480 Medtronic shares in Q2 2026, an estimated $38.7K.
- Medtronic made up ﹤0.01% of Wedge Capital Management's portfolio in Q2 2026, its #465 holding.
- Wedge Capital Management first reported a position in Medtronic in Q4 2017 and has held it in 32 quarters since.
- Wedge Capital Management's Medtronic position peaked at $46M in Q4 2017.
- 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.